Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study showed ...
Now that Beyonce has riled up the internet with her new single, titled “Formation,” and the accompanying video, the opportunity begged for GIFs to be made of her best moments. In proper Internet ...
The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...
Introduction Nintedanib and pirfenidone reduce the rate of progression in fibrotic lung diseases. Until 2024 these medications could only be prescribed by tertiary specialist centres in England. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results